Diclofenac 2% gel non-inferiority trial in acute traumatic musculoskeletal pain

Phase 3, randomised, double-blind trial in Musculoskeletal pain, joint injury, muscle strain and 3 more comparing Test diclofenac 2% gel, Reference Voltaren Emulgel 2% gel and Placebo gel (3 arms). Primary endpoint: Change from baseline in pain at rest on 100-mm visual analog scale at 96 ± 4 hours. Started Jan 2017; status: active.